Medicare Enrolled

Dr. Adelaide Hebert, M.D.

Pediatric Dermatology Physician · Bellaire, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
6500 WEST LOOP S STE 200A, Bellaire, TX 77401
7135008260
In practice since 2006 (19 years)
NPI: 1427005453 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hebert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hebert? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hebert

Dr. Adelaide Hebert is a pediatric dermatology physician in Bellaire, TX, with 19 years in practice. Based on federal Medicare data, Dr. Hebert performed 566 Medicare services across 224 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hebert received a total of $1,237,549 from 51 pharmaceutical and/or device companies across 1155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric dermatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hebert is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 566 Medicare services$ $1,237,549 industry payments

Medicare Practice Summary

Medicare Utilization ↗
566
Medicare services
0.2× state median for pediatric dermatology physician
224
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~30 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-14252$5$44
Office visit, established patient (20-29 min)177$69$223
Destruction of precancerous skin growth, 171$50$180
Office visit, established patient (10-19 min)27$43$139
Office visit, established patient (30-39 min)26$102$317
Destruction of skin growths (warts/lesions), 1-1413$90$269
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,237,549
Total received (2018-2024)
Avg $176,793/year across 7 years
Top 6% in TX for pediatric dermatology physician
51
Companies
1,155
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$740,213 (59.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$486,215 (39.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,122 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$252,660
2023
$213,988
2022
$144,292
2021
$111,334
2020
$110,515
2019
$195,822
2018
$208,938

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$524,005
Incyte Corporation
$130,038
Dermavant Sciences, Inc.
$95,941
Ortho Dermatologics, a division of Bausch Health US, LLC
$71,938
Arcutis Biotherapeutics, Inc.
$55,403
Verrica Pharmaceuticals Inc.
$32,746
LEO Pharma Inc.
$31,198
Almirall LLC
$31,091
SUN PHARMACEUTICAL INDUSTRIES INC.
$29,268
DERMIRA, INC.
$27,301
Sun Pharmaceutical Industries Inc.
$26,092
Galderma Laboratories, L.P.
$24,935
Novartis Pharmaceuticals Corporation
$20,831
Eli Lilly and Company
$20,632
SANOFI US SERVICES INC.
$17,952
Amgen Inc.
$17,090
Boehringer Ingelheim Pharmaceuticals, Inc.
$13,526
Pfizer Inc.
$11,688
VYNE Pharmaceuticals Inc.
$9,327
E.R. Squibb & Sons, L.L.C.
$8,230
UCB SA
$7,657
Janssen Global Services, LLC
$5,511
LEO Pharma AS
$4,230
Pierre Fabre Pharmaceuticals, Inc.
$3,995
Promius Pharma LLC
$3,301
Lilly USA, LLC
$3,150
Amryt Pharma Holdings Ltd
$2,600
Sanofi Pasteur Inc.
$1,678
LNHC, Inc
$1,500
Boehringer Ingelheim International GmbH
$1,000
Regeneron Healthcare Solutions, Inc.
$996
GENZYME CORPORATION
$753
ABBVIE INC.
$317
Biofrontera Inc.
$271
UCB, Inc.
$135
Journey Medical Corporation
$133
Krystal Biotech Inc
$125
Janssen Research & Development, LLC
$112
AbbVie Inc.
$109
NOVARTIS PHARMACEUTICALS CORPORATION
$100
SANOFI-AVENTIS U.S. LLC
$100
Biohaven Pharmaceuticals, Inc.
$84
Genentech USA, Inc.
$83
Mayne Pharma Inc.
$77
Janssen Biotech, Inc.
$70
MAYNE PHARMA INC.
$59
Medline Industries, Inc.
$57
Hill Dermaceuticals, Inc.
$48
Shire North American Group Inc
$26
EPI Health, LLC
$23
Celgene Corporation
$17
Top 3 companies account for 60.6% of total payments
Associated products mentioned in payments ›
ABSORICA · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Cimzia · Cloderm Cream · DISEASE STATE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · HEMANGEOL · HUMIRA · HYQVIA · ILUMYA · INFLECTRA · JUBLIA · LEVULAN KERASTICK · LITFULO · NO PRODUCT DISCUSSED · NURTEC ODT · ONEXTON · OPZELURA · ORACEA · PROTOPIC · PluroGel Burn & Wound Dressings · QBREXZA · RINVOQ · SEYSARA · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo Spray · Sernivo Spray 120ml · Seysara · Sotyktu · TALTZ · TAPINAROF · TREMFYA · TWYNEO · Tolak · VIJOICE · VTAMA · VYJUVEK · Veltin · Winlevi · XALKORI · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatric dermatology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for pediatric dermatology physician in TX.

Equivalent to $218,648 per 100 Medicare services performed
Looking for a pediatric dermatology physician in Bellaire?
Compare pediatric dermatology physicians in the Bellaire area by procedure volume, costs, and industry payment transparency.
Browse pediatric dermatology physicians nearby

Geographic Context

Pediatric Dermatology Physicians within 10 mi
7
Per 100K population
0.1
County median income
$73,104
Nearest hospital
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hebert is a clinical cardiology specialist, and high industry engagement (speaking/promotional, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hebert experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Hebert performed 252 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hebert receive payments from pharmaceutical companies?
Yes. Dr. Hebert received a total of $1,237,549 from 51 companies across 1,155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hebert's costs compare to other pediatric dermatology physicians in Bellaire?
Dr. Hebert's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hebert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →